Treating intermediate-risk pulmonary embolism (PE) with large-bore mechanical thrombectomy (LBMT) rather than catheter-directed thrombolysis (CDT) saves nearly $5,000 per patient over a lifetime horizon while delivering comparable or better outcomes, according to a new cost-effectiveness analysis.